Methods for the modulation of IL-13
US7919248B2 · kind B2 · utility
0Cited by
18References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2008 |
| Grant date | Apr 5, 2011 |
| Priority date | — |
| Expiry date | Apr 25, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is drawn to methods for modulating IL-13 expression and/or activity in a mammal comprising administering an effective amount of an agent which modulates the expression and/or activity of IL-9.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.